Here's Why Encompass Health (EHC) is a Strong Growth Stock

Encompass Health (EHC), an integrated healthcare services provider operating 166 inpatient rehabilitation hospitals, is highlighted as a strong growth stock by Zacks. The company holds a Zacks Rank #2 (Buy) with favorable VGM and Growth Style Scores of B, underpinned by a projected 18.3% year-over-year earnings growth for the current fiscal year. Analyst sentiment is positive, with eight upward revisions for fiscal 2025 estimates in the last 60 days, increasing the Zacks Consensus Estimate to $5.24 per share, complemented by a historical average earnings surprise of +14%.

Analysis

Encompass Health (EHC) exhibits a strong growth profile supported by positive analyst sentiment and robust quantitative metrics. The company, a major provider of integrated healthcare with 166 inpatient rehabilitation hospitals, holds a Zacks Rank of #2 (Buy), indicating a favorable outlook. This is further substantiated by a 'B' grade for both its Growth Style Score and its composite VGM Score. The forward-looking indicators are particularly compelling, with a forecasted year-over-year earnings growth of 18.3% for the current fiscal year. Analyst conviction has been strengthening, evidenced by eight upward earnings estimate revisions for fiscal 2025 within the last 60 days. This has lifted the Zacks Consensus Estimate for fiscal 2025 by $0.23 to $5.24 per share. Reinforcing this positive outlook is the company's historical performance, which includes an average earnings surprise of +14%, suggesting a consistent ability to exceed market expectations.

Key Decisions for Investors

• Investors with a growth-oriented mandate should consider EHC, as the combination of a #2 (Buy) rank, 18.3% projected earnings growth, and multiple upward analyst revisions signals strong near-term potential.
• Monitor upcoming earnings releases to see if the company can sustain its historical +14% average earnings surprise and meet the elevated fiscal 2025 consensus estimate of $5.24, which is now a key benchmark.
• While the provided signals are strongly positive, it is prudent to recognize they originate from a single proprietary model and should be validated against broader sector analysis, particularly regarding reimbursement trends and integrated care model adoption.